AI assistant
Protara Therapeutics, Inc. — Director's Dealing 2024
Jan 23, 2024
34057_dirs_2024-01-23_10b43d33-07bb-4d91-95ae-e633c8bb5eb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Protara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2024-01-19
Reporting Person: Bandari Jathin (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-19 | Common Stock | A | 23000 | $0.00 | Acquired | 59583 | Direct |
| 2024-01-19 | Common Stock | F | 2879 | $1.91 | Disposed | 56704 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-19 | Stock Option (Right to Buy) | $1.91 | A | 137000 | Acquired | 2034-01-18 | Common Stock (137000) | Direct |
Footnotes
F1: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024.
F2: 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
F3: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023.